Home Cart Sign in  
Chemical Structure| 177036-94-1 Chemical Structure| 177036-94-1

Structure of Ambrisentan
CAS No.: 177036-94-1

Chemical Structure| 177036-94-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Ambrisentan is an oral, once-daily endothelin receptor antagonist that is selective for the endothelin type A receptor (IC50s = 0.251, 0.316, 0.398, 251, and 630 nM for rat preparations of heart, bladder, kidney, lung, and cerebral cortex, respectively).

Synonyms: LU 208075; BSF 208075

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Ambrisentan

CAS No. :177036-94-1
Formula : C22H22N2O4
M.W : 378.42
SMILES Code : O=C(O)[C@@H](OC1=NC(C)=CC(C)=N1)C(C2=CC=CC=C2)(OC)C3=CC=CC=C3
Synonyms :
LU 208075; BSF 208075
MDL No. :MFCD08672619
InChI Key :OUJTZYPIHDYQMC-LJQANCHMSA-N
Pubchem ID :6918493

Safety of Ambrisentan

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338

Related Pathways of Ambrisentan

GPCR

Isoform Comparison

Biological Activity

Target
  • ET-A

In Vitro:

Cell Line
Concentration Treated Time Description References
THP-1-derived macrophages 100 nM ET-1 24 hours ET-1 induced macrophage inflammation, blocked by Ambrisentan pretreatment PMC10462792
Human hepatocytes (hHEP) 100 nM ET-1 24 hours ET-1/ET-A signaling did not affect hHEP senescence or proliferation PMC10462792
Human umbilical vein endothelial cells (HUVECs) 100 nM ET-1 24 hours ET-1 increased HUVEC angiogenesis, unaffected by Ambrisentan pretreatment PMC10462792
Human hepatic stellate cell (hHSC) 100 nM ET-1 24 hours ET-1 or Ambrisentan treatment did not significantly affect hHSC fibrogenesis PMC10462792
Human intrahepatic biliary epithelial cell (HIBEC) 100 nM ET-1 24 hours ET-1 induced HIBEC senescence, which was blocked by Ambrisentan pretreatment PMC10462792
MDA-MB-231 breast adenocarcinoma cells 100 µM 24 hours Ambrisentan significantly inhibited the migration and invasion capacities of MDA-MB-231 cells in a dose-dependent manner. PMC7522204
COLO-357 metastatic pancreatic adenocarcinoma cells 100 µM 48 hours Ambrisentan inhibited the migration capacity of COLO-357 pancreatic carcinoma cells in the presence or absence of PAR2 induction. PMC7522204
OVCAR3 cells 1 μM 5 minutes Inhibits ET-1-induced interaction between β-arr1 and Int β1 or talin1 PMC9886921
SKOV3 cells 1 μM 5 minutes Inhibits ET-1-induced Int β1 activation and downstream FAK/paxillin signaling PMC9886921
HL-60 promyelocytic leukemia cells 100 µM Ambrisentan blocked the migration of HL-60 promyelocytic leukemia cells. PMC7522204
OvCar3 ovarian carcinoma cells 100 µM Ambrisentan also blocked the migration of OvCar3 ovarian carcinoma cells. PMC7522204

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mdr2-/- mice Primary sclerosing cholangitis (PSC) model Intraperitoneal injections 5 mg/kg Daily for 1 week Ambrisentan reduced ductular reaction, inflammation, fibrosis, and angiogenesis in Mdr2-/- mice, and reversed cholangiocyte and vascular structural abnormalities PMC10462792
NOD/SCID mice SKOV3-Luc intraperitoneal injection model Oral 10 mg/kg Daily for 5 weeks Inhibits tumor cell adhesion and spreading to intraperitoneal organs, reduces Int β1 activity PMC9886921
Rats Monocrotaline-induced pulmonary hypertension Oral 50 mg/kg Once daily, duration not specified Evaluate the effect of selective ETA antagonist on pulmonary hypertension, results showed both selective ETA antagonist and non-selective ETA/ETB antagonist were effective in decreasing the severity of PH PMC2761178
BALB/c mice Metastatic breast cancer model Oral 10 mg/kg Daily administration for 2 weeks pre-implantation and 2 weeks post-implantation Ambrisentan treatment significantly reduced the number of metastatic foci in the lungs and liver (~43% reduction) and was associated with a significant improvement in animal survival. PMC7522204

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01467791 - Unknown January 2018 United States, Ohio ... More >> University of Cincinnati Recruiting Cincinnati, Ohio, United States, 45267 Contact: Rebecca Ingledue    513-584-6252    ingledra@ucmail.uc.edu    Principal Investigator: Robert P Baughman, MD          Sub-Investigator: Peter Engel, MD Less <<
NCT01347216 - Recruiting June 2020 Belgium ... More >> Dept. of Pneumology, University Recruiting Leuven, Belgium Contact: Marion Delcroix, MD, PhD          Principal Investigator: Marion Delcroix, MD, PhD          Germany DRK-Klinikum Köpenick Recruiting Berlin, Germany Contact: Christian Opitz, MD, PhD          Principal Investigator: Christian Opitz, MD, PhD          Lung Centre, University of Giessen Recruiting Giessen, Germany Contact: Ardeschir Ghofrani, MD, PhD          Principal Investigator: Ardeschir Ghofrani, MD          Sub-Investigator: Melanie Thamm, MD          Department of Pulmology; Hannover Medical School Recruiting Hannover, Germany Contact: Marius M Hoeper          Principal Investigator: Marius M Hoeper, MD, PhD          Sub-Investigator: Karen Olsson, MD          German Heart Centre Recruiting Munich, Germany Contact: Harald Kaemmerer, MD,. PhD          Principal Investigator: Harald Kaemmerer, MD, PhD          Ireland Mater Misericordiae Recruiting Dublin, Ireland Contact: Sean Gaine, MD, PhD          Principal Investigator: Sean Gaine, MD, PhD          Italy Department of Cardiovascular and Respiratory Sciences, University La Sapienza Recruiting Rome, Italy Contact: Dario Vizza, MD, PhD          Principal Investigator: Dario Vizza, MD, PhD          Switzerland Dept. for Rheumatology, University Hospital Recruiting Zurich, Switzerland Contact: Oliver Distler, MD, PhD          Principal Investigator: Oliver Distler, MD, PhD Less <<
NCT02565030 - Active, not recruiting October 2021 United Kingdom ... More >> Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, South Yorkshire, United Kingdom, S10 2JF Less <<
NCT01266265 - Completed - -
NCT01266265 - Completed - -
NCT02484807 - Unknown December 2016 Germany ... More >> Centre for pulmonary hypertension, Thoraxclinic at the University Hospital Heidelberg Recruiting Heidelberg, Germany, 69126 Contact: Ekkehard Grünig, MD    +496221396 ext 8053    ekkehard.gruenig@med.uni-heidelberg.de Less <<
NCT03139084 - Withdrawn(Updated results by g... More >>uidelines and bibliography) Less << December 1, 2019 -
NCT01966302 Pulmonary Arterial Hypertensio... More >>n Less << Phase 2 Active, not recruiting December 2019 United States, California ... More >> Los Angeles Biomedical research Institute Torrance, California, United States, 90502 Less <<
NCT03074149 - Recruiting April 30, 2021 Greece ... More >> Gen. Hosp. of Chest Diseases "Sotiria", Univ. Resp. Med. Recruiting Athens, Greece, 11527 Contact: Demosthenes Bouros    +302107763559    debouros@gmail.com    Sotiria Hospital Athens, 7th Pulmonary Clinic Recruiting Athens, Greece, 11527 Contact: Likourgos Kolilekas    30-2107763306    lykol@yahoo.gr    University General Hospital Attikon Recruiting Athens, Greece, 124 62 Contact: Spyros Papiris    6932646673    papiris@otenet.gr    University Hospital of Heraklion, University Pulmonology Cl Recruiting Heraklion, Greece, 71100 Contact: Aikaterini Antoniou    +302810 371966    kantoniou@med.uoc.gr    Univ. Gen. Hosp. of Larissa Recruiting Larissa, Greece, 41110 Contact: Zoe Daniil    +302413502898    zdaniil@med.uth.gr    A Pulmonology Clinic "G.Papanikolaou" Hospital Thessaloniki Recruiting Thessaloniki, Greece, 57010 Contact: Aikaterini Markopoulou    +302313307706    markopoulouk@gmail.com    General Hospital of Thessaloniki "G. Papanikolaou" Recruiting Thessaloniki, Greece, 57010 Contact: Despoina Papakosta    +302313307179    depapako@gmail.com Less <<
NCT01244620 Pulmonary Arterial Hypertensio... More >>n Less << Phase 1 Terminated(Safety Issue The tr... More >>ial was prematurely terminated on Dec 9, 2010, due to safety concerns, specifically new emerging evidence of hepatic injury.) Less << - Singapore ... More >> Pfizer Investigational Site Singapore, Singapore, 188770 Less <<
NCT01244620 - Terminated(Safety Issue The tr... More >>ial was prematurely terminated on Dec 9, 2010, due to safety concerns, specifically new emerging evidence of hepatic injury.) Less << - -
NCT00709956 - Completed - -
NCT01383083 - Unknown November 2012 -
NCT01757808 Pulmonary Arterial Hypertensio... More >>n Less << Phase 1 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT02936687 Metabolic Syndrome X Phase 1 Recruiting December 2019 United States, Wisconsin ... More >> University of Wisconsin, Madison Recruiting Madison, Wisconsin, United States, 53706 Contact: William G. Schrage, Ph.D.    608-263-6308    william.schrage@wisc.edu Less <<
NCT00554619 - Completed - -
NCT00709956 Pulmonary Arterial Hypertensio... More >>n Less << Phase 3 Completed - -
NCT00424034 Healthy Subjects Phase 1 Completed - -
NCT01352065 Pulmonary Hypertension Phase 2 Phase 3 Completed - Serbia ... More >> Center for Health, Exercise and Sport Sciences Belgrade, Serbia, 11000 Less <<
NCT01902758 Acute Mountain Sickness Phase 2 Phase 3 Completed - United States, Montana ... More >> Montana Center for Work Physiology and Exercise Metabolism Missoula, Montana, United States, 59812 Less <<
NCT00540436 - Completed - -
NCT01902758 - Completed - -
NCT00554619 Pulmonary Arterial Hypertensio... More >>n Hypertension, Pulmonary Less << Phase 3 Completed - Japan ... More >> GSK Investigational Site Aichi, Japan, 470-1192 GSK Investigational Site Hokkaido, Japan, 060-8543 GSK Investigational Site Hokkaido, Japan, 060-8648 GSK Investigational Site Ishikawa, Japan, 920-8641 GSK Investigational Site Kanagawa, Japan, 252-0375 GSK Investigational Site Kyoto, Japan, 606-8507 GSK Investigational Site Okayama, Japan, 701-1192 GSK Investigational Site Okinawa, Japan, 901-0243 GSK Investigational Site Osaka, Japan, 565-8565 GSK Investigational Site Tokyo, Japan, 113-8655 GSK Investigational Site Tokyo, Japan, 160-8582 Less <<
NCT00046319 Pulmonary Hypertension PHASE2 COMPLETED 2025-06-03 University of Southern Califor... More >>nia, Los Angeles, California, 90089, United States|University of California San Diego Medical Center, San Diego, California, 92037, United States|University of California - San Francisco, San Francisco, California, 94143, United States|Stanford University, Stanford, California, 94305, United States|Los Angeles County Harbor-UCLA Medical Center, Torrance, California, 90502, United States|University of Colorado Health Sciences Center, Denver, Colorado, 80262, United States|Rush Presbyterian, Chicago, Illinois, 60612, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|New York Presbyterian Hospital, New York, New York, 10032, United States|Case Western Reserve University, Cleveland, Ohio, 44106, United States|Ohio State University, Columbus, Ohio, 43210, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States|Baylor College of Medicine, Houston, Texas, 77030, United States|Heart Care Associates, Milwaukee, Wisconsin, 53215, United States|St. Vincent's Hospital, Sidney, Australia|Erasmus University, Brussels, Belgium|Hopital Antoine Beclere, Clamart, Cedex, 92141, France|University of Giessen, Giessen, 35392, Germany|Hannover Medical School, Hannover, 30625, Germany|University of Bologna - Institute of Cardiology, Bologna, 40136, Italy Less <<
NCT02999906 Pulmonary Arterial Hypertensio... More >>n Less << Phase 3 Withdrawn(For business reasons... More >>.) Less << June 2022 -
NCT00593905 - Unknown July 2013 United States, Pennsylvania ... More >> Allegheny General Hospital Recruiting Pittsburgh, Pennsylvania, United States, 15212 Contact: Andrea L Nowicki, BA    412-359-3653    anowicki@wpahs.org    Contact: Raymond L Benza, MD    412.359.3584    rbenza@wpahs.org    Principal Investigator: Raymond L Benza, MD Less <<
NCT01617746 Asthma Phase 2 Unknown December 2015 United Kingdom ... More >> Asthma Research Unit, University of Glasgow Not yet recruiting Glasgow, United Kingdom, G12 0YN Contact: Mark Spears, MD PhD    441412111673    mark.spears@glasgow.ac.uk    Contact: Rekha Chaudhuri, MD    441412111673    rekhachaudhuri@yahoo.com    Principal Investigator: Mark Spears, MD PhD          Sub-Investigator: Rekha Chaudhuri          Sub-Investigator: Neil C Thomson, MD FRCP Less <<
NCT02290613 Systemic Sclerosis ... More >> Pulmonary Hypertension Less << Phase 2 Active, not recruiting July 2018 Germany ... More >> Thoraxclinic at the University of Heidelberg Heidelberg, Germany, 69126 Less <<
NCT00725361 n Ulcer|Scleroderma, Systemic COMPLETED 2025-12-10 Stanford University School of ... More >>Medicine, Stanford, California, 94305, United States Less <<
NCT00423202 Pulmonary Arterial Hypertensio... More >>n Less << Phase 3 Completed - -
NCT00540436 Hypertension, Pulmonary Phase 2 Completed - Japan ... More >> GSK Investigational Site Aichi, Japan, 470-1192 GSK Investigational Site Fukuoka, Japan, 830-0011 GSK Investigational Site Hokkaido, Japan, 060-8543 GSK Investigational Site Hokkaido, Japan, 060-8648 GSK Investigational Site Ishikawa, Japan, 920-8641 GSK Investigational Site Kanagawa, Japan, 228-8555 GSK Investigational Site Kyoto, Japan, 606-8507 GSK Investigational Site Okayama, Japan, 701-1192 GSK Investigational Site Okinawa, Japan, 901-0243 GSK Investigational Site Osaka, Japan, 565-8565 GSK Investigational Site Shizuoka, Japan, 431-3192 GSK Investigational Site Tokyo, Japan, 113-8431 GSK Investigational Site Tokyo, Japan, 113-8655 GSK Investigational Site Tokyo, Japan, 143-8541 GSK Investigational Site Tokyo, Japan, 160-8582 Less <<
NCT00423748 Pulmonary Arterial Hypertensio... More >>n Less << Phase 3 Completed - -
NCT02712346 Sickle Cell Anemia Phase 1 Recruiting May 2018 United States, Georgia ... More >> Augusta University Recruiting Augusta, Georgia, United States, 30912 Contact: Leigh Wells, MSN, FNP    706-721-2171    lwells@augusta.edu    Contact: Latanya Bowman, RN, BSN    706-721-2171    lbowman@augusta.edu Less <<
NCT00091598 Pulmonary Hypertension PHASE3 COMPLETED 2025-02-06 Pulmonary Associates, PA, Phoe... More >>nix, Arizona, 85006, United States|Arizona Pulmonary Specialists, Phoenix, Arizona, 85013, United States|Brentwood Biomedical Research Institute, Los Angeles, California, 90073, United States|University of California-Davis, Sacramento, California, 95817, United States|University of California San Diego Medical Center, San Diego, California, 92037, United States|Los Angeles County Harbor-UCLA Medical Center, Torrance, California, 90502, United States|University of Colorado Health Sciences Center, Denver, Colorado, 80262, United States|Myogen, Westminster, Colorado, 80021, United States|University of Connecticut Health Center, Farmington, Connecticut, 06030, United States|Mt. Sinai Medical Center, Miami, Florida, 33140, United States|Emory University Hospital, Atlanta, Georgia, 30322, United States|Medical College of Georgia, Augusta, Georgia, 30912, United States|Loyola University Medical Center, Chicago, Illinois, 60153, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States|Ochsner Clinic, New Orleans, Louisiana, 70121, United States|Maine Medical Center, Portland, Maine, 04102, United States|Johns Hopkins University, Baltimore, Maryland, 21205, United States|Tufts New England Medical Center, Boston, Massachusetts, 02111, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|University of Michigan Medical Center, Ann Arbor, Michigan, 48109, United States|Wayne State University, Detroit, Michigan, 48201, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Washington University, St. Louis, Missouri, 63110, United States|Northshore University/Long Island Jewish Hospital, Manhasset, New York, 11030, United States|Winthrop University Hospital, Mineola, New York, 11501, United States|Mt. Sinai Medical Center, New York City, New York, 10029, United States|New York Presbyterian Hospital, New York, New York, 10032, United States|Cardiology PC, Syracuse, New York, 13210, United States|Lindner Clinical Trial Center, Cincinnati, Ohio, 45219, United States|University Hospitals of Cleveland, Cleveland, Ohio, 44106, United States|Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|Oregon Health Sciences University, Portland, Oregon, 97202, United States|University of Pennsylvania Hospital, Philadelphia, Pennsylvania, 19104, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15213, United States|Rhode Island Hospital, Providence, Rhode Island, 02903, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States|St. Paul Hospital, Dallas, Texas, 75235, United States|Baylor College of Medicine, Houston, Texas, 77030, United States|University of Texas - San Antonio, San Antonio, Texas, 78229, United States|Scott & White Hospital, Temple, Texas, 76508, United States|University of Virginia Health System, Charlottesville, Virginia, 22908, United States|Virginia Commonwealth University, Richmond, Virginia, 23298, United States|Heart Care Associates, Milwaukee, Wisconsin, 53215, United States|St. Vincent's Hospital, Sydney, New South Wales, 2010, Australia|Jewish General Hospital, Montreal, Quebec, H3T1E2, Canada Less <<
NCT01332331 Hypertension, Pulmonary Phase 2 Suspended(Ongoing juvenile rat... More >> toxicology studies.) Less << February 1, 2019 -
NCT01342952 Hypertension, Pulmonary PHASE2 COMPLETED 2022-06-09 GSK Investigational Site, Auro... More >>ra, Colorado, 80045, United States|GSK Investigational Site, Boston, Massachusetts, 02115, United States|GSK Investigational Site, Ann Arbor, Michigan, 48109-4204, United States|GSK Investigational Site, New York, New York, 10032, United States|GSK Investigational Site, Guymallen, Mendoza, 5521, Argentina|GSK Investigational Site, Ciudad de Buenos Aires, 1118, Argentina|GSK Investigational Site, Córdoba, 5000, Argentina|GSK Investigational Site, Paris, 75015, France|GSK Investigational Site, Pessac cedex, 33604, France|GSK Investigational Site, Toulouse cedex 9, 31059, France|GSK Investigational Site, Giessen, Hessen, 35385, Germany|GSK Investigational Site, Berlin, 13353, Germany|GSK Investigational Site, Budapest, 1096, Hungary|GSK Investigational Site, Roma, Lazio, 00165, Italy|GSK Investigational Site, San Donato Milanese (MI), Lombardia, 20097, Italy|GSK Investigational Site, Osaka, 565-0871, Japan|GSK Investigational Site, Tokyo, 104-8560, Japan|GSK Investigational Site, Tokyo, 143-8541, Japan|GSK Investigational Site, Kemerovo, 650002, Russian Federation|GSK Investigational Site, Moscow, 125412, Russian Federation|GSK Investigational Site, Novosibirsk, 630055, Russian Federation|GSK Investigational Site, Madrid, 28046, Spain Less <<
NCT00725361 n Ulcer|Scleroderma, Systemic COMPLETED 2025-12-10 Stanford University School of ... More >>Medicine, Stanford, California, 94305, United States Less <<
NCT00617305 Pulmonary Arterial Hypertensio... More >>n Less << Phase 4 Completed - -
NCT00840463 Pulmonary Hypertension ... More >> Heart Failure With Preserved Ejection Fraction Less << Phase 4 Terminated(Poor enrolment) - United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75390-8550 Less <<
NCT01178073 Hypertension, Pulmonary Phase 3 Completed - -
NCT00380068 Pulmonary Hypertension PHASE3 COMPLETED 2025-05-09 University of Alabama at Birmi... More >>ngham, Birmingham, Alabama, 35294, United States|Arizona Pulmonary Specialists, Ltd, Phoenix, Arizona, 85013, United States|UCSD Medical Center, Thornton Hospital, La Jolla, California, 92037, United States|Greater Los Angeles, VA Medical Center, Los Angeles, California, 90073, United States|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, 90502, United States|University of Colorado Health Sciences Center, Aurora, Colorado, 80045, United States|University of Connecticut Health Center, Farmington, Connecticut, 06030, United States|Pulmonary Hypertension Clinic Mount Sinai Medical Center, Miami Beach, Florida, 33140, United States|Suncoast Lung Center, Sarasota, Florida, 34233, United States|Medical College of Georgia, Augusta, Georgia, 30912, United States|Atlanta Institute for Medical Research, Inc., Decatur, Georgia, 30030, United States|University of Chicago Hospitals, Chicago, Illinois, 60637, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States|Johns Hopkins University, Baltimore, Maryland, 21287, United States|Tufts-New England Medical Center, Boston, Massachusetts, 02111, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Boston Adult Congenital Heart Service, Boston, Massachusetts, 02115, United States|Boston University School of Medicine, Boston, Massachusetts, 02118, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Washington University School of Medicine, St. Louis, Missouri, 63110, United States|University of Medicine & Dentistry of New Jersey, Newark, New Jersey, 07103, United States|Newark Beth Israel Medical Center, Newark, New Jersey, 07112, United States|New York Presbyterian Pulmonary Hypertension Center, New York, New York, 10032, United States|Mary Parkes Asthma Center, Rochester, New York, 14623, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|The Lindner Clinical Trial Center, Cincinnati, Ohio, 45219, United States|University Hospitals of Cleveland, Cleveland, Ohio, 44106, United States|Legacy Clinical Northwest, Portland, Oregon, 97210, United States|Allegheny General Hospital, Pittsburgh, Pennsylvania, 15212, United States|University of Pittsburgh Medical Center Presbyterian, Pittsburgh, Pennsylvania, 15213, United States|Rhode Island Hospital, Providence, Rhode Island, 02903, United States|Lexington Pulmonary and Critical Care, Lexington, South Carolina, 29072, United States|Baylor College of Medicine, Houston, Texas, 77030, United States|University of Virginia Health Sciences Center, Charlottesville, Virginia, 22908, United States|St. Vincent's Hospital, Darlinghurst, New South Wales, 2010, Australia|Royal Perth Hospital, Perth, 6000, Australia|Peter Lougheed Centre, Calgary, Alberta, T1Y 6J4, Canada|University of Alberta Hospitals, Edmonton, Alberta, T6G 2B7, Canada|Toronto General Hospital, Toronto, Ontario, M5G 2N2, Canada Less <<
NCT00617305 - Completed - -
NCT01311362 - Completed - -
NCT02958358 Pulmonary Arterial Hypertensio... More >>n Less << Not Applicable Withdrawn(inability to recruit... More >> subjects) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00423592 Pulmonary Hypertension Phase 2 Completed - -
NCT00380068 Pulmonary Hypertension PHASE3 COMPLETED 2025-05-09 University of Alabama at Birmi... More >>ngham, Birmingham, Alabama, 35294, United States|Arizona Pulmonary Specialists, Ltd, Phoenix, Arizona, 85013, United States|UCSD Medical Center, Thornton Hospital, La Jolla, California, 92037, United States|Greater Los Angeles, VA Medical Center, Los Angeles, California, 90073, United States|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, 90502, United States|University of Colorado Health Sciences Center, Aurora, Colorado, 80045, United States|University of Connecticut Health Center, Farmington, Connecticut, 06030, United States|Pulmonary Hypertension Clinic Mount Sinai Medical Center, Miami Beach, Florida, 33140, United States|Suncoast Lung Center, Sarasota, Florida, 34233, United States|Medical College of Georgia, Augusta, Georgia, 30912, United States|Atlanta Institute for Medical Research, Inc., Decatur, Georgia, 30030, United States|University of Chicago Hospitals, Chicago, Illinois, 60637, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States|Johns Hopkins University, Baltimore, Maryland, 21287, United States|Tufts-New England Medical Center, Boston, Massachusetts, 02111, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Boston Adult Congenital Heart Service, Boston, Massachusetts, 02115, United States|Boston University School of Medicine, Boston, Massachusetts, 02118, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Washington University School of Medicine, St. Louis, Missouri, 63110, United States|University of Medicine & Dentistry of New Jersey, Newark, New Jersey, 07103, United States|Newark Beth Israel Medical Center, Newark, New Jersey, 07112, United States|New York Presbyterian Pulmonary Hypertension Center, New York, New York, 10032, United States|Mary Parkes Asthma Center, Rochester, New York, 14623, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|The Lindner Clinical Trial Center, Cincinnati, Ohio, 45219, United States|University Hospitals of Cleveland, Cleveland, Ohio, 44106, United States|Legacy Clinical Northwest, Portland, Oregon, 97210, United States|Allegheny General Hospital, Pittsburgh, Pennsylvania, 15212, United States|University of Pittsburgh Medical Center Presbyterian, Pittsburgh, Pennsylvania, 15213, United States|Rhode Island Hospital, Providence, Rhode Island, 02903, United States|Lexington Pulmonary and Critical Care, Lexington, South Carolina, 29072, United States|Baylor College of Medicine, Houston, Texas, 77030, United States|University of Virginia Health Sciences Center, Charlottesville, Virginia, 22908, United States|St. Vincent's Hospital, Darlinghurst, New South Wales, 2010, Australia|Royal Perth Hospital, Perth, 6000, Australia|Peter Lougheed Centre, Calgary, Alberta, T1Y 6J4, Canada|University of Alberta Hospitals, Edmonton, Alberta, T6G 2B7, Canada|Toronto General Hospital, Toronto, Ontario, M5G 2N2, Canada Less <<
NCT00423592 - Completed - -
NCT00424021 Pulmonary Hypertension Phase 2 Completed - -
NCT01311362 - Completed - Germany ... More >> University Hospital Heidelberg Heidelberg, Germany, 69120 Less <<
NCT00851929 Sarcoidosis|Pulmonary Hyperten... More >>sion Less << PHASE2|PHASE3 COMPLETED 2025-11-11 University of North Carolina M... More >>edical Center, Chapel Hill, North Carolina, United States|Medical Univerrsity of South Carolina, Charleston, South Carolina, 29466, United States Less <<
NCT01178073 - Completed - -
NCT01971580 Single Ventricle Fontan Pallia... More >>tion Less << PHASE4 COMPLETED 2025-05-15 Washington University School o... More >>f Medicine, Saint Louis, Missouri, 63110, United States Less <<
NCT01884675 Hypertension Phase 3 Terminated - -
NCT01971580 Single Ventricle Fontan Pallia... More >>tion Less << PHASE4 COMPLETED 2025-05-15 Washington University School o... More >>f Medicine, Saint Louis, Missouri, 63110, United States Less <<
NCT00424021 - Completed - -
NCT00768300 Idiopathic Pulmonary Fibrosis Phase 3 Terminated(Lack of efficacy) - -
NCT00679224 - Completed - -
NCT01884675 - Terminated - -
NCT00879229 Idiopathic Pulmonary Fibrosis ... More >> Pulmonary Hypertension Less << Phase 3 Terminated - -
NCT01794078 Acute Mountain Sickness and Fa... More >>tigue Less << Phase 1 Completed - United States, North Carolina ... More >> Duke Center for Hyperbaric Medicine Durham, North Carolina, United States, 27710 Duke Clinical Research Unit (DCRU) Durham, North Carolina, United States, 27710 Less <<
NCT03309592 Portopulmonary Hypertension ... More >> Pulmonary Hypertension Cirrhosis, Liver Less << Phase 4 Withdrawn(Lack of eligible par... More >>ticipants and failure to meeting study enrollment.) Less << - United States, Louisiana ... More >> Ochsner Clinic Foundation New Orleans, Louisiana, United States, 70121 Less <<
NCT00879229 - Terminated - -
NCT01042158 - Completed - -
NCT01042158 Pulmonary Arterial Hypertensio... More >>n Systemic Sclerosis Scleroderma Spectrum of Diseases Connective Tissue Disease Pulmonary Hypertension Less << Phase 4 Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287 Less <<
NCT02688387 Hypertension, Pulmonary Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site London, United Kingdom, NW10 7EW Less <<
NCT00578786 - Completed - -
NCT01530464 - Completed - -
NCT01808313 Vascular Disease Phase 3 Completed - China, Heilongjiang ... More >> GSK Investigational Site Harbin, Heilongjiang, China, 150001 China, Hubei GSK Investigational Site Wuhan, Hubei, China, 430022 China, Hunan GSK Investigational Site Hunan, Hunan, China, 410008 China, Jilin GSK Investigational Site Changchun, Jilin, China, 130021 China, Shaanxi GSK Investigational Site Xian, Shaanxi, China, 710032 China, Shandong GSK Investigational Site Jinan, Shandong, China, 250012 China GSK Investigational Site Beijing, China, 100032 GSK Investigational Site Beijing, China, 100034 GSK Investigational Site Beijing, China, 100037 GSK Investigational Site Beijing, China, 100038 GSK Investigational Site Shanghai, China, 200001 GSK Investigational Site Shanghai, China, 200433 Less <<
NCT01338636 Exercise-induced Pulmonary Art... More >>erial Hypertension Less << PHASE4 COMPLETED 2025-05-16 Brigham and Women's Hospital, ... More >>Boston, Massachusetts, 02115, United States Less <<
NCT01808313 - Completed - -
NCT01530464 High Altitude Pulmonary Hypert... More >>ension Less << Phase 1 Completed - United States, North Carolina ... More >> Duke Clinical Research Unit Durham, North Carolina, United States, 27710 Less <<
NCT01093885 Systemic Sclerosis|Scleroderma COMPLETED 2025-07-16 University of Pennsylvania Hea... More >>lth System, Philadelphia, Pennsylvania, 19104, United States Less <<
NCT00768300 - Terminated(Lack of efficacy) - -
NCT00578786 Pulmonary Arterial Hypertensio... More >>n Less << Phase 3 Completed - Argentina ... More >> Sanatorio Otamendi Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina, C1115AAB Hospital Britanico-Buenos Aires Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina, C1280AEB Instituto del Corazon Denton A. Cooley Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina, C1416A UAI Hosp. Universitario Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina, C1437BZL HIGA Hospital Interzonal General de Agudos Oscar Allende Mar del Plata, Buenos Aires, Argentina, 07600 Clinica Independencia Munro Munro, Buenos Aires, Argentina, 01605 Hospital Italiano de Rosario Rosario, Sante Fe, Argentina, 02000 Sanatorio Allende Cordoba, Argentina, X5000JHQ Hospital Italiano de Cordoba Cordoba, Argentina, X5004 FJE Hospital Privado Centro Medico de Cordoba Cordoba, Argentina, X5016KEH Instituto de Cardiologia J.F. Cabral Corrientes, Argentina, W3400AMZ Brazil Hospital Universitario Clementino Fraga Filho Ilha do Fundao, Rio de Janeiro, Brazil, 21941-590 Hospital Madre Teresa Belo Horizonte, Brazil, 30380-090 Hospital San Lucas de Pontificia Universidade Catolica Porto Alegre, Brazil, 90610-000 Complexo Hospitalar Sanata Casa de Porto Alegre Porto Alegre, Brazil, 92020-090 Universidade do Estado de Sao Paulo - UNIFESP Sao Paulo, Brazil, 04023-062 Hospital das Clinicas da FMUSP Sao Paulo, Brazil, 05403-000 Chile Hospital San Juan de Dios Santiago, Santiago de Chile, Chile, CP 8330024 Hospital Clinico Universidad Catolica Santiago, Santiago de Chile, Chile, CP 8350488 Instituto Nacional del Torax Santiago, Santiago de Chile, Chile, CP7500691 Mexico Instituto Nacional de Cardiologia Ignacio Chavez Mexico, DF, DF, Mexico, 14080 Unidad De Investigacion Clinica en Medicina Monterrey, Nuevo Leon, Nuevo Leon, Mexico, 64718 Less <<
NCT01338636 Exercise-induced Pulmonary Art... More >>erial Hypertension Less << PHASE4 COMPLETED 2025-05-16 Brigham and Women's Hospital, ... More >>Boston, Massachusetts, 02115, United States Less <<
NCT01051960 Systemic Sclerosis|Shortness o... More >>f Breath|Pulmonary Hypertension Less << PHASE4 COMPLETED 2025-01-11 David Geffen School of Medicin... More >>e, University of California, Los Angeles, Los Angeles, California, 90095, United States Less <<
NCT01894022 Hypertension Phase 3 Terminated - -
NCT01406327 Hypertension, Pulmonary COMPLETED 2020-02-28 -
NCT01093885 Systemic Sclerosis|Scleroderma COMPLETED 2025-07-16 University of Pennsylvania Hea... More >>lth System, Philadelphia, Pennsylvania, 19104, United States Less <<
NCT01733095 Portopulmonary Hypertension Phase 1 Phase 2 Withdrawn(slow recruitment) - Austria ... More >> Medical University of Graz Graz, Austria, 8036 Less <<
NCT00777920 Pulmonary Hypertension PHASE3 COMPLETED 2019-09-11 University of Alabama at Birmi... More >>ngham, Birmingham, Alabama, 35294, United States|Arizona Pulmonary Specialists, Phoenix, Arizona, 85013, United States|University of Colorado Health Science Center, Aurora, Colorado, 80045, United States|University of Connecticut Health Center, Farmington, Connecticut, 06030, United States|Atlanta Institute for Medical Research, Inc., Atlanta, Georgia, 30030, United States|University of Iowa, Iowa City, Iowa, 52242, United States|Tufts Medical Center, Boston, Massachusetts, 02111, United States|BACH Cardiology/Children's Hospital, Boston, Massachusetts, 02115, United States|Brigham & Women's Hospital, Boston, Massachusetts, 02115, United States|Boston University Medical Center, Boston, Massachusetts, 02118, United States|Washington University Medical Center, Saint Louis, Missouri, 63110, United States|Newark Beth Israel Medical Center, Newark, New Jersey, 07112, United States|Mary Parkes Asthma Center University of Rochester, Rochester, New York, 14623, United States|University of Pittsburgh Medical Center Presbyterian, Pittsburgh, Pennsylvania, 15213, United States|Rhode Island Hospital, Providence, Rhode Island, 02903, United States|Lexington Pulmonary and Critical Care Medicine, Lexington, South Carolina, 29072, United States|Clinica Independencia Munro, Buenos Aires, 1605, Argentina|Instituto de Investigaciones Clínicas Mar del Plata, Buenos Aires, B7600FZN, Argentina|Sanatorio Otamendi y Miroli, Buenos Aires, C1115AAb, Argentina|Hospital Británico de Buenos Aires, Buenos Aires, C1280AEB, Argentina|UAI Hospital Universitario, Buenos Aires, C1437BZL, Argentina|Fundación Rusculleda, Cordoba, X5003DCE, Argentina|Instituto de Cardiologia Hospital Italiano de Cordoba, Cordoba, X5004FJE, Argentina|Hospital Privado Centro Medico de Cordoba S.A., Cordoba, X5016KEH, Argentina|Instituto de Cardiologia J.F. Cabral, Corrientes, W3400AMZ, Argentina|Hospital Italiano, Rosario, S2001ODA, Argentina|St. Vincent's Hospital, Darlinghurst, New South Wales, 2010, Australia|Royal Perth Hospital, Perth, Western Australia, 6000, Australia|Instituto de Pneumologia e Pediatria Clínica e Pesquisas LTDA ME, Belo Horizonte, 30380-090, Brazil|UBEA, Hospital Sao Lucas de Pontifícia, Porto Alegre, 90610 000, Brazil|Irmandade Santa Casa de Misericordia de Porto Alegre, Porto Alegre, 92020-090, Brazil|Hospital Universitario Clementino Fraga Filho, Rio de Janeiro, 21949-900, Brazil|Universidade do Estado de Sao Paulo - UNIFESP, Sao Paulo, 4023-062, Brazil|Hospital das Clinicas da FMUSP, Sao Paulo, CEP05403-000, Brazil|Peter Lougheed Centre, Calgary, Alberta, T1Y 6J4, Canada|Centro de Estudios Cardiologicos Santiago Oriente, Santiago, 7500503, Chile|Instituto Nacional del Torax, Santiago, 7500691, Chile|Hospital Clinico de la Pontificia Universidad Catolica de Chile, Santiago, 8330074, Chile|Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, 14080, Mexico|Unidad de Investigacion Clinica en Medicina S.C., Monterrey, 64718, Mexico|State Medico Stomatologic University, Moscow, 109263, Russian Federation|Russian Cardiology Research Complex, Moscow, 121552, Russian Federation|Almazov's Federal Heart, Blood & Endocrinology Center, St. Petersburg, 194156, Russian Federation|Pavlov's State Medical University of St. Petersburg, St. Petersburg, 197022, Russian Federation|Department of Acute Myocardial Infarction, Kharkov, 61039, Ukraine|Department of Propedeutics of Internal Medicine No 1, Kiev, 3049, Ukraine Less <<
NCT02080637 Hypoplastic Left Heart Syndrom... More >>e Hypoplastic Right-sided Heart Complex Less << Phase 2 Active, not recruiting July 2019 United States, North Carolina ... More >> Duke Universtiy Hospital Durham, North Carolina, United States, 27710 Less <<
NCT01072669 - Completed - -
NCT02169752 Pre-Pulmonary Atrial Hypertens... More >>ion Less << TERMINATED 2017-05-25 National Jewish Health, Denver... More >>, Colorado, 80206, United States Less <<
NCT01330108 Pulmonary Arterial Hypertensio... More >>n Less << Phase 4 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35249 Less <<
NCT01224210 Portopulmonary Hypertension PHASE3 COMPLETED 2025-03-20 UCSD Medical Center, La Jolla,... More >> California, 92093, United States|Mayo Clinic Florida, Jacksonville, Florida, 32224, United States|Tufts Medical Center, Boston, Massachusetts, 02111, United States|University of North Carolina, Chapel Hill, North Carolina, 27599, United States|The Ohio State University Medical Center, Columbus, Ohio, 43221, United States|UT Southwestern Medical Center, Dallas, Texas, 75390, United States Less <<
NCT01330108 - Completed - -
NCT01072669 Ischemia Not Applicable Completed - United States, Ohio ... More >> Nilanjana Bose, Md Cleveland, Ohio, United States, 44195 Less <<
NCT02253394 Pulmonary Arterial Hypertensio... More >>n Less << Phase 4 Recruiting January 2019 United States, Massachusetts ... More >> Brigham & Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Principal Investigator: Bradley Maron, MD Less <<
NCT01894022 - Terminated - -
NCT02885012 Pulmonary Arterial Hypertensio... More >>n Less << PHASE4 TERMINATED 2017-07-07 Ochsner Medical Center, New Or... More >>leans, Louisiana, 70121, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States Less <<
NCT05437224 Pulmonary Arterial Hypertensio... More >>n Less << PHASE3 COMPLETED 2022-02-06 Renji Hospital, Shanghai, 2001... More >>27, China Less <<
NCT03827200 Cirrhosis|Portal Hypertension|... More >>Ascites Less << PHASE2 TERMINATED 2021-01-21 Hospital Clinic Barcelona, Bar... More >>celona, Catalunya, 08036, Spain|Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, 28222, Spain|Vall d'Hebron University Hospital, Barcelona, 08035, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, 08041, Spain|Hospital Universitario Gregorio Mara?ón, Madrid, 28007, Spain|Hospital Universitario Ramón y Cajal, Madrid, 28034, Spain Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.64mL

0.53mL

0.26mL

13.21mL

2.64mL

1.32mL

26.43mL

5.29mL

2.64mL

References

 

Historical Records

Categories